業績 – 英文

2018

• New diagnostic criteria of adrenal subclinical Cushing’s syndrome: opinion from the Japan Endocrine Society.
  Yanase T, Oki Y, Katabami T, Otsuki M, Kageyama K, Tanaka T, Kawate H, Tanabe M, Doi M, Akehi Y, Ichijo T.
  Endocr J. 2018 Apr 26;65(4):383-393. doi: 10.1507/endocrj.EJ17-0456. Epub 2018 Mar 23.

2015

• Sekiguchi Y, Miyamoto Y, Kasahara I, Hara Y, Tani Y, Doi M, Hirata Y.
  Ectopic ACTH syndrome caused by desmopressin-responsive thymic neuroendocrine tumor.
  Endocr J. 2015;62(5):441-447.

2012

• Tateishi, Y. Kouyama, R. Mihara, M. Doi, M. Yoshimoto, T. Hirata, Y.
  Evaluation of salivary cortisol measurements for the diagnosis of subclinical Cushing’s syndrome.
  Endocr J. 2012;59(4):283-289.

2011

• Akaza I, Yoshimoto T, Iwashima F, Nakayama C, Doi M, Izumiyama H, Hirata Y.
  Clinical outcome of subclinical Cushing’s syndrome after surgical and conservative treatment.
  Hypertens Res. 2011;34(10):1111-1115.
• Hiraishi K, Yoshimoto T, Tsuchiya K, Minami I, Doi M, Izumiyama H, Sasano H, Hirata Y.
  Clinicopathological features of primary aldosteronism associated with subclinical Cushing’s syndrome.
  Endocr J. 2011;58(7):543-551.

2010

• Doi M, Sugiyama T, Izumiyama H, Yoshimoto T, Hirata Y.
  Clinical features and management of ectopic ACTH syndrome at a single institute in Japan.
  Endocr J. 2010;57(12):1061-1069. Epub 2010 Nov 9.
• Wago T, Yoshimoto T, Akaza I, Tsuchiya K, Izumiyama H, Doi M, Hirata Y.
  Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan.
  Hypertens Res. 2010;33(8):796-801. Epub 2010 Jun 17.
• Sakihara S, Kageyama K, Oki Y, Doi M, Iwasaki Y, Takayasu S, Moriyama T, Terui K, Nigawara T, Hirata Y, Hashimoto K, Suda T.
  Evaluation of plasma, salivary, and urinary cortisol levels for diagnosis of Cushing’s syndrome.
  Endocr J. 2010;57(4):331-337. Epub 2010 Feb 7.

2009

• Oki Y, Hashimoto K, Hirata Y, Iwasaki Y, Nigawara T, Doi M, Sakihara S, Kageyama K, Suda T.
  Development and validation of a 0.5 mg dexamethasone suppression test as an initial screening test for the diagnosis of ACTH-dependent Cushing’s syndrome.
  Endocr J. 2009;56(7):897-904. Epub 2009 Aug 25.
• Akaza I, Tsuchiya K, Akaza M, Sugiyama T, Izumiyama H, Doi M, Yoshimoto T, Hirata Y.
  Improvement of congestive heart failure after octreotide and transsphenoidal surgery in a patient with a cromegaly.
  Intern Med. 2009;48(9):697-700. Epub 2009 May 1.

2008

• Minami I, Yoshimoto T, Hirono Y, Izumiyama H, Doi M, Hirata Y: Diagnostic Accuracy of Adrenal Venous Sampling in Comparison with Other Parameters in Primary Aldosteronism. Endocr J. 2008 May 2008;:23.
• Doi M, Sekizawa N, Tani Y, Tsuchiya K, Kouyama R, Tateno T, Izumiyama H, Yoshimoto T, Hirata Y: Late-night salivary cortisol as a screening test for the diagnosis of Cushing’s syndrome in Japan. Endocr J 55 2008;:121-126.
• Sakai H, Tsuchiya K, Nakayama C, Iwashima F, Izumiyama H, Doi M, Yoshimoto T, Tsujino M, Yamada S, Hirata Y: Improvement of Endothelial Dysfunction in Acromegaly after Transsphenoidal Surgery. Endocr J. 2008 May 2008;:28.
• Tani Y, Tateno T, Izumiyama H, Doi M, Yoshimoto T, Hirata Y: Defective Expression of Prohormone Convertase 4 and Enhanced Expression of Insulin-like Growth Factor II by Pleural Solitary Fibrous Tumor Causing Hypoglycemia. Endocr J. 2008 Jun 2008;:14.

2007

• Gotyo N, Doi M, Izumiyama H, Hirata Y: Secondary adrenal insufficiency caused by adult development of pituitary stalk transection. Intern Med 46 2007;:1711-1715.
• Tateno T, Izumiyama H, Doi M, Akashi T, Ohno K, Hirata Y: Defective expression of prohormone convertase 1/3 in silent corticotroph adenoma. Endocr J 54 2007;:777-782.
• Tateno T, Izumiyama H, Doi M, Yoshimoto T, Shichiri M, Inoshita N, Oyama K, Yamada S, Hirata Y: Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Eur J Endocrinol 157 2007;:717-724.
• Tsuchiya K, Nakayama C, Iwashima F, Sakai H, Izumiyama H, Doi M, Hirata Y: Advanced endothelial dysfunction in diabetic patients with multiple risk factors; importance of insulin resistance. J Atheroscler Thromb 14 2007;:303-309.

2006

• Fukai N, Hirono Y, Yoshimoto T, Doi M, Ohtsuka Y, Homma K, Shibata H, Sasano H, Hirata Y: A case of estrogen-secreting adrenocortical carcinoma with subclinical Cushing’s syndrome. Endocr J 53 2006;:237-245.
• Izumiyama H, Gotyo N, Fukai N, Ozawa N, Doi M, Yoshimoto T, Arii S, Hirata Y: Glucose-responsive and octreotide-sensitive insulinoma. Intern Med 45 2006;:519-524.
• Minami I, Tateno T, Yoshimoto T, Doi M, Izumiyama H, Akashi T, Hirata Y: Subclinical Cushings disease with amelioration of metabolic comorbidities after removal of pituitary tumor. Intern Med 45 2006;:1231-1235.
• Sakai H, Matsumoto K, Sugiyama M, Yoshimoto T, Doi M, Izumiyama H, Hirata Y: A case of factitious adrenal insufficiency after vascular graft surgery caused by spurious immunometric assays. Endocr J 53 2006;:415-419.
• Tsuchiya K, Ohta K, Yoshimoto T, Doi M, Izumiyama H, Hirata Y: A Case of acromegaly associated with subclinical Cushing’s disease. Endocr J 53 2006;:679-685.

2005

• Hirono Y, Doi M, Yoshimoto T, Kanno K, Himeno Y, Taki K, Sasano H, Hirata Y: A case with primary aldosteronism due to unilateral multiple adrenocortical micronodules. Endocr J 52 2005;:435-439.
• Tsuchiya K, Minami I, Tateno T, Izumiyama H, Doi M, Nemoto T, Mae S, Kasuga T, Osamura RY, Oki Y, Hirata Y: Malignant gastric carcinoid causing ectopic ACTH syndrome: discrepancy of plasma ACTH levels measured by different immunoradiometric assays. Endocr J 52 2005;:743-750.
• Yoshimoto T, Doi M, Fukai N, Izumiyama H, Wago T, Minami I, Uchimura I, Hirata Y: Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Intern Med 44 2005;:1174-1177.

2003

• Doi M, Imai T, Shichiri M, Tateno T, Fukai N, Ozawa N, Sato R, Teramoto K, Hirata Y: Octreotide-sensitive ectopic ACTH production by islet cell carcinoma with multiple liver metastases. Endocr J 50 2003;:135-143.

2002

• Doi M, Shichiri M, Katsuyama K, Ishimaru S, Hirata Y: Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis 160 2002;:123-132.
• Okamoto H, Tamada A, Hai N, Doi M, Uchimura I, Hirata Y, Kosugi S: A novel six-nucleotide insertion in exon 4 of the MEN1 gene, 878insCTGCAG, in three patients with familial insulinoma and primary hyperparathyroidism. Jpn J Clin Oncol 32 2002;:368-370.

2000

• Doi M, Shichiri M, Katsuyama K, Marumo F, Hirata Y: Cytokine-activated p42/p44 MAP kinase is involved in inducible nitric oxide synthase gene expression independent from NF-kappaB activation in vascular smooth muscle cells. Hypertens Res 23 2000;:659-667.
• Doi M, Shichiri M, Yoshida M, Marumo F, Hirata Y: Suppression of integrin alpha(v) expression by endothelin-1 in vascular smooth muscle cells. Hypertens Res 23 2000;:643-649.

1999

• Shichiri M, Kato H, Doi M, Marumo F, Hirata Y: Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Mol Endocrinol 13 1999;:1353-1363.